Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-20 Purchase | 2024-03-25 11:05 am | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 170,589 | $2.95 | $503,238 | 3,989,053 (Indirect Direct) | View |
| 2024-03-18 Purchase | 2024-03-19 4:19 pm | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 113,777 | $3.01 | $342,469 | 3,818,464 (Indirect Direct) | View |
| 2023-07-19 Sale | 2023-07-20 8:01 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 101,900 | $2.7516 | $280,387 | 3,522,136 (Direct) | View |
| 2023-07-14 Sale | 2023-07-18 8:27 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 38,600 | $2.7467 | $106,024 | 3,624,036 (Direct) | View |
| 2023-06-30 Sale | 2023-07-03 6:29 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 200,937 | $2.6341 | $529,288 | 3,662,636 (Direct) | View |
| 2023-06-26 Sale | 2023-06-28 9:35 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 40,415 | $1.7764 | $71,794 | 3,863,573 (Direct) | View |
| 2023-06-21 Sale | 2023-06-23 7:17 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 13,298 | $1.9454 | $25,870 | 3,903,988 (Direct) | View |
| 2023-06-15 Sale | 2023-06-20 5:53 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 16,729 | $2.0335 | $34,019 | 3,917,286 (Direct) | View |
| 2023-06-12 Sale | 2023-06-14 8:18 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 6,398 | $2.098 | $13,423 | 3,934,015 (Direct) | View |
| 2022-12-07 Purchase | 2022-12-08 5:09 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 21,202 | $1.3 | $27,563 | 362,340 (Indirect Direct) | View |
| 2022-07-20 Sale | 2022-07-22 6:52 pm | Cyteir Therapeutics Inc. | CYT | Novo Holdings A/S 10% Owner | 900,000 | $3 | $2,700,000 | 3,940,413 (Direct) | View |
| 2022-05-12 Purchase | 2022-05-16 4:24 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 743 | $1.61 | $1,196 | 341,138 (Indirect Direct) | View |
| 2022-05-10 Purchase | 2022-05-12 4:38 pm | Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director | 10,000 | $2 | $20,000 | 10,000 (Direct) | View |
| 2022-05-10 Purchase | 2022-05-12 4:35 pm | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 50,406 | $1.8862 | $95,077 | 340,395 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-03-19 4:09 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Leonard Braden Michael 10% Owner | 0 | $0 | 3,704,687 (Indirect) | View |
| 2024-02-29 Exercise | 2024-03-05 6:11 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 3,239 | $1.68 | 287,064 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:11 pm | N/A 2030-12-10 | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 10,358 | $0 | 287,064 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:11 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 7,119 | $1.69 | 287,064 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 2,537 | $1.2 | 1,551,261 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 21,448 | $0 | 1,551,261 (Direct) | View |
| 2024-02-29 Exercise | 2024-03-05 6:10 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 18,911 | $1.69 | 1,551,261 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 4:00 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $0 | 2,458,415 (Direct) | View |
| 2024-02-14 Exercise | 2024-02-16 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $1.69 | 2,458,415 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-14 4:01 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director | 12,129 | $0 | 12,129 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-14 4:01 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director | 12,129 | $1.69 | 12,129 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 4:00 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director | 12,828 | $0 | 22,828 (Direct) | View |
| 2024-02-08 Exercise | 2024-02-12 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director | 12,828 | $1.69 | 22,828 (Direct) | View |
| 2024-02-06 Exercise | 2024-02-08 4:11 pm | 2024-02-03 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $0 | 376,490 (Direct) | View |
| 2024-02-06 Exercise | 2024-02-08 4:11 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $1.69 | 376,490 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 1,620 | $1.68 | 201,639 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-14 4:00 pm | N/A 2030-12-10 | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 3,993 | $0 | 201,639 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 2,373 | $1.69 | 201,639 (Direct) | View |
| 2023-11-20 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 2,536 | $1.2 | 1,324,309 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-14 4:00 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 8,840 | $0 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-12-14 4:00 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 6,304 | $1.69 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 27,900 | $1.2 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 84,637 | $0 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:48 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 56,737 | $1.69 | 1,324,309 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 52,584 | $1.68 | 201,639 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:47 pm | N/A 2030-12-10 | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 73,940 | $0 | 201,639 (Direct) | View |
| 2023-11-20 Exercise | 2023-11-22 1:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 21,356 | $1.69 | 201,639 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:48 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Zakrzewski Joseph S Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:47 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | THERO JOHN F Director | 12,828 | $0 | 12,828 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:46 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Sands Stephen H. Director | 12,129 | $0 | 12,129 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:45 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Romberger Timothy Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:44 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Molineaux Susan Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:43 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Humphrey Jeffrey Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:42 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | George Jean Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:42 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Bracken Racquel Director | 14,150 | $0 | 14,150 (Direct) | View |
| 2023-01-13 Option Award | 2023-02-07 4:41 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 5,000 | $1.49 | 123,000 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:41 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 113,900 | $0 | 123,000 (Direct) | View |
| 2021-12-20 Exercise | 2023-02-07 4:38 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 4,100 | $1.68 | 77,739 (Direct) | View |
| 2021-12-20 Exercise | 2023-02-07 4:38 pm | N/A 2030-12-10 | Cyteir Therapeutics Inc. | CYT | Gaiero David G Chief Financial Officer | 4,100 | $0 | 77,739 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:14 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 96,100 | $0 | 96,100 (Direct) | View |
| 2023-01-13 Option Award | 2023-02-07 4:08 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 5,000 | $1.49 | 1,286,336 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 4:08 pm | N/A 2033-02-03 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 302,600 | $0 | 1,286,336 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 30,437 | $1.2 | 1,011,709 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A 2028-12-10 | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 136,782 | $0 | 1,011,709 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-23 4:47 pm | N/A N/A | Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO | 106,345 | $1.03 | 1,011,709 (Direct) | View |
| 2022-05-02 Option Award | 2022-05-04 4:22 pm | N/A 2032-04-25 | Cyteir Therapeutics Inc. | CYT | Veness Adam M General Counsel | 177,000 | $0 | 177,000 (Direct) | View |